Six of fourteen studies reported statistically significant (P < 0.05) expression changes for DLK1, demonstrating lower expression of the gene in prostate cancer tissues relative to healthy control tissues in four studies and higher expression in two. This evidence concerns the gene DLK1 and Familial prostate cancer.